<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ZYNEX RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Sat, 04 Apr 2026 08:34:09 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/zynex%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>ZYNEX RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>Zynex Financial Restructuring Puts Company on Path to Long-Term Success</title><pubDate>Tue, 16 Dec 2025 14:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/zynex-financial-restructuring-puts-company-on-path-to-long-term-success-15361791</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">ENGLEWOOD, Colo., <span class="legendSpanClass"><span class="xn-chron">Dec. 16, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/zynex-financial-restructuring-puts-company-on-path-to-long-term-success-15361791</guid></item><item><title>Zynex verkündete Quartalsergebnis zum jüngsten Jahresviertel</title><pubDate>Wed, 19 Nov 2025 06:35:07 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/zynex-verkuendete-quartalsergebnis-zum-juengsten-jahresviertel-15290296</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/zynex-aktie">Zynex</a> stellte am 17.11.2025 die jüngste Quartalsbilanz zum am 30.09.2025 abgelaufenen Quartal vor.Der Verlust je Aktie belief sich auf 1,42 USD. Im Vorjahresquartal hatten 0,070 USD je Aktie in den Büchern gestanden.Der  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/zynex-verkuendete-quartalsergebnis-zum-juengsten-jahresviertel-15290296</guid></item><item><title>Zynex Reports Third Quarter 2025 Financial Results</title><pubDate>Mon, 17 Nov 2025 23:15:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/zynex-reports-third-quarter-2025-financial-results-15286004</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">ENGLEWOOD, Colo., <span class="legendSpanClass"><span class="xn-chron">Nov. 17, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/zynex-reports-third-quarter-2025-financial-results-15286004</guid></item><item><title>Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee</title><pubDate>Fri, 14 Nov 2025 14:15:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/zynex-announces-strategic-initiatives-engagement-of-province-appointment-of-paul-aronzon-to-board-of-directors-and-formation-of-special-committee-15276460</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">ENGLEWOOD, Colo., <span class="legendSpanClass"><span class="xn-chron">Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/zynex-announces-strategic-initiatives-engagement-of-province-appointment-of-paul-aronzon-to-board-of-directors-and-formation-of-special-committee-15276460</guid></item><item><title>Zynex Sets Third Quarter 2025 Earnings Call</title><pubDate>Fri, 14 Nov 2025 14:00:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/zynex-sets-third-quarter-2025-earnings-call-15276422</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">ENGLEWOOD, Colo., <span class="legendSpanClass"><span class="xn-chron">Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/zynex-sets-third-quarter-2025-earnings-call-15276422</guid></item><item><title>Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair</title><pubDate>Wed, 15 Oct 2025 00:07:00 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/zynex-announces-appointment-of-bret-wise-to-board-of-directors-as-audit-committee-chair-15052170</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">ENGLEWOOD, Colo., <span class="legendSpanClass"><span class="xn-chron">Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/zynex-announces-appointment-of-bret-wise-to-board-of-directors-as-audit-committee-chair-15052170</guid></item></channel></rss>
